Delivering PrEP to Young Women in a Low-Income Setting in South Africa: Lessons for Providing Both Convenience and Support.

Autor: Cassidy T; Médecins Sans Frontières, Cape Town, South Africa. talicassidy@gmail.com.; Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. talicassidy@gmail.com., Ntuli N; Médecins Sans Frontières, Cape Town, South Africa., Kilani C; Médecins Sans Frontières, Cape Town, South Africa., Malabi N; Médecins Sans Frontières, Cape Town, South Africa., Rorwana B; Médecins Sans Frontières, Cape Town, South Africa., Mutseyekwa T; Médecins Sans Frontières, Cape Town, South Africa., O'Connell R; Médecins Sans Frontières, Cape Town, South Africa., Steele SJ; Southern African Medical Unit, Cape Town, South Africa., Ndlovu Z; Southern African Medical Unit, Cape Town, South Africa., Ellman T; Southern African Medical Unit, Cape Town, South Africa., de Azevedo V; City Health Department, Cape Town, South Africa., Pfaff C; Médecins Sans Frontières, Cape Town, South Africa., Nelson A; Médecins Sans Frontières, Cape Town, South Africa., Duran LT; Médecins Sans Frontières, Cape Town, South Africa.
Jazyk: angličtina
Zdroj: AIDS and behavior [AIDS Behav] 2022 Jan; Vol. 26 (1), pp. 147-159. Date of Electronic Publication: 2021 Jul 14.
DOI: 10.1007/s10461-021-03366-x
Abstrakt: Daily oral pre-exposure prophylaxis (PrEP) is a key tool in addressing high HIV incidence among young women, and breaking the cycle of transmission. From 2017 to 2020, Médecins Sans Frontières (MSF) offered PrEP, in conjunction with contraception and risk-reduction counselling, to women aged 18-25, in a government-run clinic in Khayelitsha, a low income high HIV prevalence area in South Africa. Drawing on clinical, quantitative, and qualitative interview data, we describe participants' experiences and engagement with the PrEP program, participant adherence (measured by TFV-DP levels in dried blood spots) over time, and the indirect benefits of the PrEP program. Of 224 screened and eligible participants, 164 (73.2%) initiated PrEP, with no large differences between those who initiated and those who did not. Overall, 47 (29%) completed 18 months follow-up, with 15 (9.1%) attending all visits. 76 (46.9%) participants were lost to follow-up, 15 (9.1%) exited when leaving the area, and 28.7% of exits happened in the first month of the study. We identified two different trajectories of PrEP adherence: 67% of participants had, on average, consistently low TFV-DP levels, with the remaining 33% having sustained high adherence. Few baseline characteristics predicted good adherence. The main reported barrier to taking PrEP was forgetting to take or travel with the pills. Encouragement from others declined as a reported facilitator from month 6 to 18 (family: 93.1% vs 77.6%, p = 0.016, friends: 77.6% vs 41.4%, p ≤ 0.001, partners: 62.1% vs 46.6%, p = 0.096, other PrEP users: 89.7% vs 74.1%, p = 0.020). Disclosure to friends and family in some cases opened dialogue around sex, and helped to educate others about PrEP. Self-reported sex with more than one partner, and sex without a condom, decreased significantly after enrolment (p < 0.001, p = 0.063). In the individual interviews, participants credited their PrEP experience with changing their behaviour. Recognising the challenges with, but overall benefits from a package of care that includes the option of PrEP, lessons drawn from this study can help maximise persistence on PrEP within resource constraints. PrEP providers need to address participants' need for both convenience and social support.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz: